Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: Neuronal cell-specific translation defects

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1467-1474

  Haller, Aurelia A ^a,b   Stewart, Stacey R ^a   Semler, Bert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; NERVOUS TISSUE; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERTANT; RNA SEQUENCE; VIRUS ATTENUATION; VIRUS MUTANT; VIRUS TRANSCRIPTION;

BASE SEQUENCE; DEFECTIVE VIRUSES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEURONS; NUCLEIC ACID CONFORMATION; POLIOVIRUS; PROTEIN BIOSYNTHESIS; RNA, VIRAL; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0030050632     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1467-1474.1996     Document Type: Article

References (40)

1. Agol, V. I. 1990. Current approaches to the problem of poliovirus attenuation, p. 311-318. In M A. Brinton and F. X Heinz (ed ) New aspects of positive-strand RNA viruses. American Society for Microbiology, Washington, D.C
2. Bodian, D. 1955. Emerging concept of poliomyelitis infection. Science 12:105-108.
3. Borman, A. M., F. G. Deliat, and K. M. Kean. 1994. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J. 13:3149-3157.
4. Brodeur, G. M., G. S. Sekhon, and M. N. Goldstein. 1977. Chromosomal aberrations in human neuroblastomas Cancer 40:2256-2253.
5. Brown, B. A., and E. Ehrenfeld. 1979 Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology 97:396-405.
6. Dildine, S. L., K. R. Stark, A. A. Haller, and B. L. Semler. 1991. Poliovirus translation initiation: differential effects of directed and selected mutations in the 5′ noncoding region of viral RNAs. Virology 182:742-752
7. Dorner, A. J., B. L. Semler, R. J. Jackson, R. Hanecak, E. Duprey, and E. Wimmer. 1984. In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J. Virol. 50:507-514.
8. Evans, D. M. A., G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann, G. Stanway, J. W. Almond, K. Currey, and J. V. Maizel, Jr. 1985. Increased neurovirulence associated with a single nucleotide change in a non-coding region of the Sabin type 3 poliovaccine genome. Nature (London) 314:548-550.
9. Gmyl, A. P., E. V. Pilipenko, S. V. Mastova, G. A. Belov, and V. I. Agol. 1993. Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5′-untranslated region yield a variety of pseudorevertants J. Virol. 67:6309-6316.
10. Hagino-Yamagishi, K., and A. Nomoto. 1989. In vitro construction of poliovirus defective interfering particles. J. Virol. 63:5386-5392.
11. Haller, A. A., J. H. C. Nguyen, and B. L. Semler. 1993. Minimum internal ribosome entry site required for poliovirus infectivity. J. Virol. 67:7461-7471.
12. Haller, A. A., and B. L. Semler. 1992. Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J. Virol. 66:5075-5086.
13. Haller, A. A., and B. L. Semler. 1995. Translation and host cell shutoff, p. 113-133. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
14. Helentjaris, T., E. Ehrenfeld, M. L. Brown-Luedi, and J. W. B. Hershey. 1979. Alterations in initiation factor activity from poliovirus-infected HeLa cells. J. Biol. Chem. 254:10973-10978
15. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans Virology 15:312-326.
16. Iizuka, N., M. Kohara, K. Hagino-Yamagishi, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J. Virol. 63:5354-5363.
17. Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:1302-1309.
18. Kitamura, N., B. L. Semler, P. G. Rothberg, G. R. Larsen, C. J. Adler, A. J. Dorner, E. A. Emini, R. Hanecak, J. J. Lee, S. van der Werf, C. W. Anderson, and E. Wimmer. 1981. Primary structure, gene organization, and polypeptide expression of poliovirus RNA. Nature (London) 291:547-553.
19. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
20. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol 63:2357-2360
21. Lawson, M. A., B. Dasmahapatra, and B. L. Semler. 1990. Species-specific substrate interactions of picornavirus 3C proteinase suballelic exchange mutants. J. Biol. Chem. 265:15920-15931.
22. Macadam, A. J., G. Ferguson, J. Burlison, D. Stone, R. Skuce, J. W. Almond, and P. D. Minor. 1992. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 189:415-422.
23. Nomoto, A., M. Kohara, S. Kuge, N. Kawamura, M. Arita, T. Kamatsu, S. Abe, B. L. Semler, E. Wimmer, and H. Itoh. 1987. Study on virulence of poliovirus type 1 using in vitro modified viruses, p 437-452. In M. A. Brinton and R. R. Rueckert (ed.), Positive-strand RNA viruses. Alan R. Liss, Inc., New York
24. Nomoto, A., and E. Wimmer. 1987. Genetic studies of the antigenicity and the attenuation phenotype of poliovirus. Symp. Soc Gen. Microbiol 40:107-134.
25. Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (London) 334:320-325
26. Pilipenko, E. V., V. M. Blinov, L. I. Romanova, A. N. Sinyakov, S. V. Maslova, and V. I. Agol. 1989. Conserved structural domains in the 5′-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201-209.
27. Racaniello, V. R., and D. Baltimore. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl Acad. Sci. USA 78:4887-4891.
28. Ren, R., and V. R. Racaniello. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol 66:296-304
29. Rivera, V. M., J. D. Welsh, and J. V. Maizel. 1988. Comparative sequence analysis of the 5′ noncoding region of the enteroviruses and rhinoviruses. Virology 165:42-50.
30. Roehl, H. H., and B. L. Semler. 1995. Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3′ end of viral negative-strand RNA. J. Virol. 69:2954-2961.
31. Rueckert, R. R. 1991. Picornaviridae and their replication, p. 409-450. In B. N. Fields and D. M. Knipe (ed.), Fundamental virology, 2nd ed Raven Press, New York.
32. Sabin, A. B. 1956. Pathogenesis of poliomyelitis: reappraisal in light of new data. Science 123:1151-1157.
33. Schwab, M., K. Alitalo, K.-H. Klempnauer, H. E. Varmus, J. M. Bishop, F. Gilbert, G. Brodeur, M. Goldstein, and J. Trent. 1983. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (London) 305:245-248.
34. Shepley, M. P., and V. R. Racaniello. 1994. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J. Virol. 68:1301-1308.
35. Shiroki, K., T. Ishii, T. Aoki, M. Kobashi, S. Ohka, and A. Nomoto. 1995 A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:6825-6832.
36. Skinner, M. A., V. R. Racaniello, G. Dunn, J. Cooper, P. D. Minor, and J. W. Almond. 1989. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol 207:379-392.
37. Svitkin, Y. V., S. V. Maslova, and V. I. Agol. 1985. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243-252.
38. Svitkin, Y. V., T. V. Pestova, S. V. Maslova, and V. I. Agol. 1988. Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 166: 394-404.
39. Toyoda, H., M. Kohara, Y. Kataoka, T. Suganuma, T. Omata, N. Imura, and A. Nomoto. 1984. Complete nucleotide sequences of all three poliovirus serotype genomes: implication for genetic relationship, gene function and antigenic determinants. J. Mol. Biol. 174:561-585.
40. Wimmer, E., J. J. Harber, J. A. Bibb, M. Gromeier, H.-H. Lu, and G. Bernhardt. 1994. Poliovirus receptors, p. 101-127. In E. Wimmer (ed.), Cellular receptors for animal viruses Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N Y.